BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mutchnick MG, Lerner E, Conn HO. Effect of portacaval anastomosis on hypersplenism. Dig Dis Sci. 1980;25:929-938. [PMID: 7004809 DOI: 10.1007/bf01308044] [Cited by in Crossref: 37] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Karasu Z, Gurakar A, Kerwin B, Hulagu S, Jazzar A, McFadden R, Nour B, Sebastian A, Cassidy F, Stokes K, Van Thiel DH, Wright H. Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis. Dig Dis Sci. 2000;45:1971-1976. [PMID: 11117569 DOI: 10.1023/a:1005694617983] [Cited by in Crossref: 28] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
2 Kong L, Li M, Li L, Jiang L, Yang J, Yan L. Splenectomy before adult liver transplantation: a retrospective study. BMC Surg 2017;17:44. [PMID: 28427382 DOI: 10.1186/s12893-017-0243-9] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Ishigami M, Ishizu Y, Onishi Y, Kamei H, Kiuchi T, Itoh A, Hirooka Y, Katano Y, Goto H. Long-term dynamics of hematological data and spleen volume in cirrhotic patients after liver transplantation-various dynamics depending on etiology. Springerplus 2013;2:374. [PMID: 24010032 DOI: 10.1186/2193-1801-2-374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Qamar AA, Grace ND. Abnormal hematological indices in cirrhosis. Can J Gastroenterol 2009;23:441-5. [PMID: 19543577 DOI: 10.1155/2009/591317] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
5 Yanaga K, Tzakis AG, Shimada M, Campbell WE, Marsh JW, Stieber AC, Makowka L, Todo S, Gordon RD, Iwatsuki S. Reversal of hypersplenism following orthotopic liver transplantation. Ann Surg. 1989;210:180-183. [PMID: 2667473 DOI: 10.1097/00000658-198908000-00007] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 1.7] [Reference Citation Analysis]
6 Shi BM, Wang XY, Mu QL, Wu TH, Xu J. Value of portal hemodynamics and hypersplenism in cirrhosis staging. World J Gastroenterol. 2005;11:708-711. [PMID: 15655827 DOI: 10.3748/wjg.v11.i5.708] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
7 Sanyal AJ. The use and misuse of transjugular intrahepatic portasystemic shunts. Curr Gastroenterol Rep. 2000;2:61-71. [PMID: 10981005 DOI: 10.1007/s11894-000-0053-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kercher KW, Carbonell AM, Heniford BT, Matthews BD, Cunningham DM, Reindollar RW. Laparoscopic splenectomy reverses thrombocytopenia in patients with hepatitis C cirrhosis and portal hypertension. J Gastrointest Surg. 2004;8:120-126. [PMID: 14746844 DOI: 10.1016/j.gassur.2003.10.009] [Cited by in Crossref: 62] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
9 Sekiguchi T, Nagamine T, Takagi H, Mori M. Autoimmune thrombocytopenia in response to splenectomy in cirrhotic patients with accompanying hepatitis C. World J Gastroenterol 2006;12:1205-10. [PMID: 16534872 DOI: 10.3748/wjg.v12.i8.1205] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
10 Gemery JM, Forauer AR, Silas AM, Hoffer EK. Hypersplenism in liver disease and SLE revisited: current evidence supports an active rather than passive process. BMC Hematol 2016;16:3. [PMID: 26865982 DOI: 10.1186/s12878-016-0042-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
11 Goulis J, Chau TN, Jordan S, Mehta AB, Watkinson A, Rolles K, Burroughs AK. Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation. Gut. 1999;44:754-758. [PMID: 10205219 DOI: 10.1136/gut.44.5.754] [Cited by in Crossref: 101] [Cited by in F6Publishing: 86] [Article Influence: 4.6] [Reference Citation Analysis]
12 Wang D, Lu JG, Wang Q, Du XL, Dong R, Wang P, Zhao L, Jiang X, Yuan LJ. Increased immunohistochemical expression of YKL-40 in the spleen of patients with portal hypertension. Braz J Med Biol Res 2012;45:264-72. [PMID: 22267006 DOI: 10.1590/s0100-879x2012007500010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Jabbour N, Zajko A, Orons P, Irish W, Fung JJ, Selby RR. Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis? Dig Dis Sci. 1998;43:2459-2462. [PMID: 9824134 DOI: 10.1023/a:1026634215918] [Cited by in Crossref: 36] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
14 Karasu Z, Tekin F, Ersoz G, Gunsar F, Batur Y, Ilter T, Akarca US. Liver fibrosis is associated with decreased peripheral platelet count in patients with chronic hepatitis B and C. Dig Dis Sci. 2007;52:1535-1539. [PMID: 17464564 DOI: 10.1007/s10620-006-9144-y] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
15 Qamar AA, Grace ND, Groszmann RJ, Garcia-Tsao G, Bosch J, Burroughs AK, Ripoll C, Maurer R, Planas R, Escorsell A, Garcia-Pagan JC, Patch D, Matloff DS, Makuch R, Rendon G; Portal Hypertension Collaborative Group. Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. Clin Gastroenterol Hepatol. 2009;7:689-695. [PMID: 19281860 DOI: 10.1016/j.cgh.2009.02.021] [Cited by in Crossref: 136] [Cited by in F6Publishing: 108] [Article Influence: 11.3] [Reference Citation Analysis]